Recent INMB News
- INmune Bio Inc. Announces First Quarter 2024 Results and Provides Business Update • GlobeNewswire Inc. • 05/09/2024 08:05:36 PM
- INmune Bio Inc. to Report First Quarter 2024 Financial Results and Provide a Corporate Update on Thursday, May 9 • GlobeNewswire Inc. • 05/07/2024 12:00:00 PM
- INmune Bio Inc. Provides Update on Two Patients from the Phase 1b Alzheimer’s Disease Trial who Continue to Receive XPro™ Under Compassionate Use for Over Three Years • GlobeNewswire Inc. • 04/30/2024 12:00:00 PM
- INmune Bio Inc. Completes First Cohort and Initiates Second Cohort of Phase 1/2 Study of INKmune™ Natural Killer Cell Therapy in Patients with Metastatic Castration-Resistant Prostate Cancer • GlobeNewswire Inc. • 04/29/2024 12:00:00 PM
- INmune Bio Inc. Announces $9.7 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules • GlobeNewswire Inc. • 04/25/2024 01:00:00 PM
- INmune Bio Inc. Announces 24-Month Stability Validation of XPro™ for Phase III Readiness and Commercial Supply Chain Modeling & Development of Novel Immunogenicity Assay • GlobeNewswire Inc. • 04/23/2024 12:00:00 PM
- INmune Bio Inc. Raises Approximately $4.8 Million in Gross Proceeds Through Registered Direct Offering with Officers, Employees and Directors Purchasing Approximately 20% of the Offering • GlobeNewswire Inc. • 04/22/2024 12:00:00 PM
- INmune Bio Inc. Presents Data on INB03’s Role as an Immune Check Point Modulator in the Treatment of High-Risk Breast Cancer at AACR 2024 • GlobeNewswire Inc. • 04/08/2024 12:00:00 PM
- INmune Bio Inc. Announces Year End 2023 Results and Provides a Q4 Business Update • GlobeNewswire Inc. • 03/28/2024 08:01:53 PM
- INmune Bio Inc. to Report Fourth Quarter 2023 Financial Results and Provide a Corporate Update on Thursday, March 28 • GlobeNewswire Inc. • 03/26/2024 08:01:00 PM
- INmune Bio CSO and Co-Founder Mark Lowdell, Ph.D. Receives The ISCT Career Achievement Award in Cell and Gene Therapy • GlobeNewswire Inc. • 03/13/2024 12:00:00 PM
- INmune Bio Reports Significant EEG Improvement in Alzheimer’s Patients Treated with XPro™ • GlobeNewswire Inc. • 03/05/2024 01:00:00 PM
- INmune Bio to Participate in the Oppenheimer 34th Annual Healthcare Life Sciences Conference • GlobeNewswire Inc. • 02/12/2024 02:00:00 PM
- INmune Bio to Participate in Baird’s Biotech Discovery Series Webcast on February 13, 2024 • GlobeNewswire Inc. • 02/06/2024 02:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/30/2024 01:02:36 PM
- INmune Bio Announces FDA Removal of Clinical Hold for Alzheimer’s Disease Program • GlobeNewswire Inc. • 01/30/2024 01:00:00 PM
- ELEVAI Labs, Inc. Acquires Worldwide License Agreement for Proprietary Stem Cell Manufacturing Technology • GlobeNewswire Inc. • 01/16/2024 01:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2024 09:00:28 PM
- INmune Bio Announces First Patient Dosed in a Phase 1/2 Study of INKmune™ in Patients with Metastatic Castration-Resistant Prostate Cancer • GlobeNewswire Inc. • 01/02/2024 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/18/2023 09:15:31 PM
- Form 8-A12B/A - Registration of securities [Section 12(b)]: [Amend] • Edgar (US Regulatory) • 12/18/2023 09:05:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/18/2023 09:01:18 PM
- INmune Bio Provides Update Regarding Global Alzheimer’s Phase II Clinical Trial and Clinical Hold Issued by the United States FDA • GlobeNewswire Inc. • 12/18/2023 09:01:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/29/2023 09:00:09 PM
- INmune Bio Inc. Demonstrates that INB03 Enhances the Uptake of Trastuzumab Deruxtecan in HER2+ Breast Cancer with MUC4 Expression in Poster Presented at San Antonio Breast Cancer Symposium • GlobeNewswire Inc. • 11/29/2023 01:00:00 PM
FEATURED POET Announces Design Win and Collaboration with Foxconn Interconnect Technology for High-speed AI Systems • May 14, 2024 10:09 AM
FEATURED Element79 Gold Corp Reports Exceptionally High-Grade Results from Lucero • May 14, 2024 7:00 AM
VAYK Added New Manager for Expansion into $64 Billion Domestic Short-term Rental Market • VAYK • May 14, 2024 9:00 AM
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM